Key statistics
As of last trade Hansa Biopharma AB (24H:FRA) traded at 3.45, -28.21% below its 52-week high of 4.80, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.45 |
---|---|
High | 3.45 |
Low | 3.45 |
Bid | 3.43 |
Offer | 3.60 |
Previous close | 3.43 |
Average volume | 0.00 |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.71bn SEK |
EPS (TTM) | -14.59 SEK |
Data delayed at least 15 minutes, as of Sep 27 2024 08:16 BST.
More ▼
Press releases
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
- Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update
- Hansa Biopharma to host Q2 2024 interim results conference call